Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

5.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.1K
Therapeutic Index01:13

Therapeutic Index

5.1K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
5.1K
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

1.2K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Implementing virtual diabetes self-management education in two health systems (VIDA): a mixed-methods pilot study.

Frontiers in clinical diabetes and healthcare·2026
Same author

A comparative meta-analysis of stress shielding between short-stem and conventional femoral stem in total hip arthroplasty.

BMC musculoskeletal disorders·2026
Same author

Fast Estimation and Valid Statistical Inference for Mixed-Effect Location-Scale Models Using Variational Inference.

Statistics in medicine·2026
Same author

A Longitudinal, Real-World Study of the Relationship between Levothyroxine Dose and Suboptimal Hypothyroidism Treatment.

Thyroid : official journal of the American Thyroid Association·2026
Same author

Impact of Hypothyroidism on Short-Term and Long-Term Outcomes of Coronary Artery Bypass Graft Surgery.

Thyroid : official journal of the American Thyroid Association·2026
Same author

The Impact of State Certification and Medicaid Reimbursement on Community Health Worker Place of Employment and Wages: United States, 2012-2023.

American journal of public health·2026

相关实验视频

Updated: Sep 16, 2025

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

14.7K

使用基于TSH的"时间范围"来测量甲状腺功能低下症疾病控制.

Matthew D Ettleson1, Nikita Thomas2, Marcelo Ramirez1

  • 1Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, IL 60637.

The Journal of clinical endocrinology and metabolism
|July 11, 2025
PubMed
概括

甲状腺刺激激素 (TSH) 的时间范围 (TIR) 反映了甲 (LT4) 治疗控制. 男性性别和黑人种族等社会人口统计因素与较低的TIR有关,这表明甲状腺功能低下症管理中的差异.

关键词:
甲状腺功能低下症 甲状腺功能低下症莱沃甲氧氨酸 (Levothyroxine) 是一种抗氧化剂.纵向分析是一种纵向分析.护理的质量 护理质量

更多相关视频

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

1.9K
Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

981

相关实验视频

Last Updated: Sep 16, 2025

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

14.7K
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

1.9K
Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

981

科学领域:

  • 内分泌学 在内分泌学.
  • 临床研究 临床研究
  • 健康结果的健康结果.

背景情况:

  • 利沃甲状腺素 (LT4) 治疗是治疗甲状腺功能低下症的标准.
  • 甲状腺刺激激素 (TSH) 水平是治疗疗效的关键指标.
  • 时间范围 (TIR) 为评估慢性疾病控制提供了一个新的指标.

研究的目的:

  • 开发一种方法来估计LT4治疗患者的TSH TIR.
  • 分析社会人口统计学因素对TIR的影响.
  • 探索TIR和心血管事件之间的相关性.

主要方法:

  • 利用了来自2752名LT4治疗患者 (2016-2022) 的纵向临床数据.
  • 估计TIR,时间上限 (TAR) 和时间下限 (TBR) 使用日志转换TSH的线性插值.
  • 采用通用估计方程和生存分析来评估共变量和事件关联.

主要成果:

  • 平均TIR为86%,平均随访时间为3.8年.
  • 在男性和女性中,LT4剂量与TIR负相关.
  • 男性性别和黑人种族与TIR <75%显著相关.

结论:

  • TSH TIR估计有效地确定了在甲状腺功能低下症控制中的社会人口学差异.
  • LT4剂量影响TIR,在不同患者群体中观察到差异.
  • 需要进一步的研究来将TIR与显著的临床结果联系起来.